abstract |
FIELD: pharmacy. n SUBSTANCE: invention relates to 5-bromonicotinic acid derivatives: , where R 1 is hydrogen; R 2 is 4-methoxy-6-methyl-1,3,5-triazile-2, or a hydrogen proton or a 2-methyl-1,2,4-triazolyl-1. The compounds can be used in clinical practice for cardiac rhythm correction. n EFFECT: creation of a new compound with anti-arrhythmic activity. n 2 tbl |